IPO registrations (S-1, F-1) · Registrants
Shuttle Pharmaceuticals Holdings, Inc.
- SEC CIK
- 1757499 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2022-06-03, last 2026-02-11; 9 initial registrations, 11 amendments
- Outcome
- Final prospectus filed 2022-08-31; declared effective 2022-08-29; withdrawal requested 2025-01-22
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 401 PROFESSIONAL DRIVE, SUITE 260, Gaithersburg, MD 20879
- Ticker
- SHPH (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Shuttle Pharmaceuticals Holdings, Inc. on the corporate pages
On this site
- Form D issuer: Shuttle Pharmaceuticals Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: Shuttle Pharmaceuticals Holdings, Inc. EXACT (CIK (EXACT))
Filings 31
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-06-03 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-015884 ↗ |
| 2022-06-23 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-017616 ↗ |
| 2022-07-13 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-019110 ↗ |
| 2022-08-19 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-023497 ↗ |
| 2022-08-24 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-023883 ↗ |
| 2022-08-25 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-024040 ↗ |
| 2022-08-25 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-024083 ↗ |
| 2022-08-29 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-22-002534 ↗ |
| 2022-08-31 | 424B4 | 424B4 (final prospectus) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-22-024431 ↗ |
| 2023-01-25 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-23-002473 ↗ |
| 2023-01-30 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-23-002842 ↗ |
| 2023-02-01 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-23-000256 ↗ |
| 2024-04-05 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-24-013368 ↗ |
| 2024-09-20 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-24-037194 ↗ |
| 2024-10-18 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-24-041510 ↗ |
| 2024-10-29 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-24-003304 ↗ |
| 2024-10-31 | 424B4 | 424B4 (final prospectus) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-24-043154 ↗ |
| 2025-01-15 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-25-002253 ↗ |
| 2025-01-22 | RW | RW (withdrawal request) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-25-003122 ↗ |
| 2025-01-23 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-25-000173 ↗ |
| 2025-02-13 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-25-006202 ↗ |
| 2025-03-05 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-25-009106 ↗ |
| 2025-03-07 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-25-000609 ↗ |
| 2025-08-05 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001641172-25-022101 ↗ |
| 2025-08-11 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-25-002564 ↗ |
| 2025-11-18 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-25-024089 ↗ |
| 2025-12-11 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-25-027310 ↗ |
| 2026-01-30 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-26-000384 ↗ |
| 2026-02-11 | S-1 | S-1 (registration) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-26-006073 ↗ |
| 2026-02-11 | S-1/A | S-1/A (amendment) | Shuttle Pharmaceuticals Holdings, Inc. | 0001493152-26-006220 ↗ |
| 2026-02-17 | EFFECT | EFFECT (declared effective) | Shuttle Pharmaceuticals Holdings, Inc. | 9999999995-26-000617 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Adkins William | Director; Other | 2 | 2022–2023 | ||
| Dritschilo Anatoly | Director,Officer,TenPercentOwner | CEO and Chairman | 4 | 2022–2023 | |
| Dritschilo Peter | Officer | President and COO | 2 | 2022 | |
| Jung Mira | Officer | Chief Scientific Officer | 3 | 2022–2024 | |
| Richards Steven M | Director | 5 | 2022–2025 | ||
| Rich Tyvin | Officer | Chief Medical Officer | 2 | 2022–2023 | |
| Schafer Joshua | Director | 3 | 2022–2025 | ||
| Senanayake Chris | Director | 2 | 2022–2024 | ||
| Vander Hoek Michael | Officer | Chief Financial Officer | 3 | 2022–2024 | |
| Brown Milton | Director | 5 | 2022–2025 | ||
| Jacobs Bette | Director | 3 | 2022–2023 | ||
| Lorber Timothy J. | Officer | Chief Financial Officer | 2 | 2024–2025 | |
| Nabyt Oleh | Director | 2 | 2025 | ||
| Scorsis George | Director | 2 | 2025 | ||
| Tung Joseph | Director | 2 | 2025 | ||
| Cooper Chris | Officer | Interim Co-CEO | 1 | 2025 | |
| Chambers Adam V | Director | 1 | 2025 | ||
| Pathigoda Arachchige Sachin Eranga | Director | 1 | 2025 | ||
| Liriano Angel | Director | 1 | 2025 | ||
| Liang Yuying | Officer | Chief Financial Officer | 1 | 2026 | |
| Trasolini Ryan | Officer | Co-Chief Executive Officer | 1 | 2026 | |
| HRT FINANCIAL LP | TenPercentOwner | 8 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-05-15 | Shuttle Pharmaceuticals Holdings, Inc. | Other Technology | $9,955,000 | $9,955,000 | 47 | 1 |
| 2025-11-07 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | $2,500,624 | $2,499,998 | 1 | 1 |
| 2025-06-26 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | $4,250,000 | $4,250,000 | 1 | 1 |
| 2024-10-25 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | $1,300,000 | $790,000 | 5 | 1 |
| 2023-01-20 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | $4,000,000 | $4,000,000 | 1 | 1 |
| 2022-08-15 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | $500,000 | $125,000 | 3 | 1 |
| 2022-02-22 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | $2,000,000 | $365,000 | 11 | 1 |
| 2022-01-04 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | $500,000 | $500,000 | 2 | 1 |
| 2019-01-31 | Shuttle Pharmaceuticals Holdings, Inc. | Pharmaceuticals | Indefinite | $912,500 | 18 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.